T he genome represents much more than a passive library of genetic information. It functions as an information-retrieval device instructed to dynamically change conformation to expose the genetic information required for a particular cell type under a particular cellular situation. It is now thought that distinct changes in the three-dimensional (3D) arrangement of our (epi)genomes occur in association with development, physiological responses, aging, response to diet, environmental stress and/or learning. Just as a map of the world is more than a list of places and street names, the nuclear genome is more than a string of letters and can be described as a complex choreography of proteins and nucleic acids that interact differentially over time. How these complex DNA-based functions are achieved within the constrained nuclear space, and how the chromatin context of any given gene is regulated, remained elusive until recently.
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New technologies are paving the way for exploration of the structure and dynamics of chromatin 1, 2 , and future developments integrating different approaches offer further promises. Indeed, we now face the great challenge of taking the linear genome sequence provided by the Human Genome Project 3, 4 , decorated with the valuable annotations provided by the ENCODE, Roadmap and FANTOM projects, among others 5 , and creating an integrated 4D understanding of the complexity of the cell nucleus. Given the remarkable technologies and data sets now available, it is time to launch a concerted effort toward characterizing the dynamic organization of the genome and the rules that govern determination and maintenance of cell types (see, for example, recent complementary initiatives in US, NIH4DNucleome 6 ; Europe, EU-4DNucleome and LifeTime; and Japan, Japan-4DNucleome). We envisage a complete 3D atlas in time (4D) of nuclei within the thousands of cell types that form an organism.
The 4D nucleome is a rapidly evolving field that has been exponentially growing since the 1980s, just as the protein structure field exploded in the 1960s once the first structures of proteins emerged. The establishment of the Protein Data Bank (PDB) 7 and its associated structural format was instrumental for the sharing of information, allowing structural data to revolutionize biochemistry, protein engineering approaches and drug design. However, as huge amounts of structural information accumulated, it became clear that to maximize the utility and reliability of the structural models, standardized and validated pipelines for data processing were needed, and the massive storage of standardized data sets were required in addition to mere 3D coordinates. First the X-ray crystallography community 8, 9 , and later other groups 10, 11 , decided to address this challenge, and the PDB has been evolving toward a standardized, validated metadata repository. The 4D nucleome community is at a turning point and must now address a similar challenge. Due to recent advances in experimental and theoretical approaches, the dynamic three-dimensional organization (3D) of the nucleus has become a very active area of research in life sciences. We now understand that the linear genome is folded in ways that may modulate how genes are expressed during the basic functioning of cells. Importantly, it is now possible to build 3D models of how the genome folds within the nucleus and changes over time (4D). Because genome folding influences its function, this opens exciting new possibilities to broaden our understanding of the mechanisms that determine cell fate. However, the rapid evolution of methods and the increasing complexity of data can result in ambiguity and reproducibility challenges, which may hamper the progress of this field. Here, we describe such challenges ahead and provide guidelines to think about strategies for shared standardized validation of experimental 4D nucleome data sets and models.
Challenges and guidelines toward
Assessment of genome and epigenome structural and dynamic data from molecular genomics, imaging and computational modeling requires agreement on a series of validation pipelines that the community should adopt, as well as data sharing strategies and accepted formats for depositing the data. This is a nontrivial issue given the rapid evolution of technologies, the variety of methods used and the intrinsically multidimensional nature of the problem. Moreover, proper translation of the data into biological insight with subsequent functional validations represents a major challenge. Next, we briefly review the state of the art of each of the standardization and validation approaches to study and interpret nuclear organization.
Molecular genomics
The 4D nucleome community has developed and implemented genomic technologies that allow an integrated investigation of gene expression, epigenetic marks, nucleosome localization and genome interactions, both for cell populations and at the single-cell level. These technologies rely on the use of high-throughput experimental approaches and next-generation sequencing (NGS) to characterize genome organization and chromatin status at the molecular level. Information retrieved from sequencing provides data of protein occupancy at specific genomic regions, nucleosome organization, DNA methylation and 3D chromatin associations, which enable multiresolution information on chromatin structure to be deduced and modeled.
For example, nucleosome positioning techniques are based on sequencing of chromatin after DNA digestion that treats nucleosome-bound compared to unbound (linker) DNA differentially. Several technologies have been developed that differ mainly in the way DNA is digested or how DNA-protein interactions are identified 12, 13 . Promoter and enhancer accessibility data are key for understanding regulation of gene expression, and assay for transposase-accessible chromatin using sequencing (ATAC)-seq has emerged as a tool to probe this aspect 14 . All these approaches present challenges that need to be addressed to validate and standardize the resulting data sets, especially for single-cell experiments in which the data are sparse and cannot be replicated. For example, the data can be noisy, biased by sequence preferences of processing enzymes, cross-linking reagents, antibody specificity, and standard sequence biases of NGS. Moreover, nucleosomes are sliding along the sequence, which means they do not have fixed positions, but probability distributions are observed, which require very deep sequencing to be reliable. Importantly, nucleosome positioning data sets almost invariably represent an average map, which has to be considered in light of cell-to-cell variability, something that requires complex deconvolution of the detected signals into unique nucleosome families. Recently, single-cell and single-molecule mapping variants of some of these technologies provided an exciting perspective while raising the challenge of gathering epigenomic maps from intrinsically scattered data [15] [16] [17] . Although these approaches provide a steady state picture of the epigenome, an emerging class of time-resolved methods should ultimately enable its dynamic characterization at multiple time scales. Indeed, histone dynamics have been studied genome-wide on a time scale of minutes [18] [19] [20] . An emerging microfluidics-based methodology also allows tracking of site-specific protein-DNA contact kinetics on a time scale of seconds by measuring cross-linking kinetics 21 .
Other approaches use fusion constructs to characterize protein residence time on DNA, exploiting a time course of MNase digestion 22 or the anchor-away system 23 . Although the diversity of experimental systems provides great promise, comparing these methods has proven difficult. The building of integrated models of the 4D nucleome should tackle these limitations and solve the problem of translating linear nucleosome distributions into time-dependent 3D arrangements consistent with time-resolved imaging data.
Chromosome conformation capture techniques (3C) 24 come in various flavors 25 . These approaches are limited by a number of potential issues, including the degree of cross-linker fixation, nuclear permeabilization, as well as solubilization, digestion and ligation efficiencies. Other more specific issues such as oligonucleotide design exist for 5C and capture Hi-C. Data processing and bioinformatic analyses of "C" data are complex, and approaches for quality control and normalization remain an open challenge. This is particularly important given the blooming of experimental variations on the main technology, each carrying different advantages, limitations and potential sources for bias. Common standards do not yet exist, which is becoming a major challenge for the ability to compare different data sets to obtain meaningful conclusions. We need to perform extensive benchmarking of the experimental and computational analyses to reach a consensus on standards 26 . Furthermore, validation with independent technologies is needed. Direct comparison with data sets from orthogonal approaches, such as those from genome architecture mapping (GAM) 27 , and imaging offers great promise toward defining gold standards [28] [29] [30] [31] . Though this should mature, newer approaches will continue to emerge. For example, in GAM 27 , C-Walks 32 or SPRITE 33 , more than two chromatin contacts can be captured and analyzed. This calls for setting up dedicated analytical tools and pipelines and further testing with complementary technologies, such as high-throughput microscopy.
Light and electron microscopy
DNA and RNA FISH have long been used to evaluate the location and activity of genomic loci and the position of whole chromosomes in situ at the single-cell level. The limitations in spatial resolution, throughput, and genomic coverage have been major challenges. However, the advent of 3D high-throughput (deepimaging) and super-resolution imaging (nanoscopy) technologies coupled with novel DNA/RNA labeling strategies are now enabling the visualization of genomic domains, individual genes and single transcripts in 3D. Novel approaches to tag chromosomal domains include multiplexing probes by oligopaints or antibody labeling in fixed cells 30, [34] [35] [36] . Well-known technologies for live imaging involve the use of stem-loop structures in RNAs and fluorescent viral proteins that recognize these tags (MS2/MCP or PP7) 37, 38 , as well as bacterial operator arrays that can be visualized by fluorescently tagged repressor proteins and other "fluorescent repressor operator systems" (FROS) [39] [40] [41] . New labeling techniques take advantage of protein oligomerization such as Suntag 42 or ANCHOR 43 . The advent of CRISPR-inactive Cas9-bound guide RNAs for fluorescently tagging DNA 44, 45 or transcription activator-like effectors (TALE) 46, 47 is changing the landscape of visualization options when fused to fluorescent proteins to enable the visualization of naturally occurring repetitive sequences. Each of these systems is likely to have its specific limitations and may potentially interfere with chromatin biology in a context-dependent manner as reported for lacO FROS 48 or CRISPR-based tagging systems 49 . However, several reports recapitulate the live-cell imaging results (TetO-tagged loci in embryonic stem cells) in fixed cells 50, 51 , suggesting that these approaches are not generally disruptive of genome architecture and function. SNAP-or CLIP-tag technologies 52, 53 for labeling proteins, fluorescent antibody fragments 54 and development of new, brighter dyes offer seemingly unlimited possibilities to probe nanoscale structures of chromatin. As these methods rely on fusion proteins (with potential hindrance to their function) or antibodies (with potential specificity issues), integrating results from multiple approaches will be critical. Photoactivable or SNAP-tag-based approaches can also be used to measure protein dynamics in the nucleus 55 , together with fluorescence recovery after photobleaching (FRAP), fluorescence correlation spectroscopy (FCS) and single-molecule tracking methods. Analytical methods to integrate data from these approaches are a subject of intense research 31, 35 . In the past 10 years, super-resolution imaging of single molecules has paved the way for an even more detailed analysis of chromatin structural variations within the nucleus 56, 57 . In particular, it is now possible to beat the diffraction limit using structured illumination microscopy (SIM), reaching 120 nm lateral resolution, and to reach even deeper using stochastic optical reconstruction microscopy (STORM) or photoactivated localization microscopy (PALM), which can reach 20-nm lateral resolution, i.e., a full order of magnitude better than regular confocal microscopy.
An experimental challenge for single-molecule imaging in live nuclei is the need to capture the rapid 3D motion of nuclear factors (diffusion coefficient ~10 μ m 2 /s). The recently developed multifocal microscope (MFM) enables the parallel acquisition of up to twentyfive focal planes 58, 59 . One can thus image cellular volumes over an axial depth of ~5 μ m, comparable to the size of eukaryotic nuclei, with acquisition rates of up to hundreds of times faster than conventional methods 60, 61 . Standard fluorescence signals can now also be captured in thick samples with light-sheet microscopy, which, together with aberration-corrected multifocus microscopes, will enable time-lapse imaging that is many fold faster and has much less bleaching than conventional spinning-disk or wide-field fluorescence microscopy 58 .
In fixed cells, chromatin fibers can be visualized by chromatin EM tomography 62 . Combined light microscopy-electron microscopy (CLEM) provides locus-specific labeling by fluorescence and either conventional EM or serial blockface scanning electron microscopy (SBF-EM) ultrastructural information of the entire nucleus, cell or tissue. 3D EM can now also be correlated with time-lapse fluorescence imaging in living cells 63 . Finally, SBF-EM 64 enables 3D reconstruction of cellular structures at nanometer resolution.
Altogether, it is now clear that chromatin structure is becoming accessible to the microscope on all levels of resolution, as are longrange contacts through the 3C technologies. Indeed, light imaging has enabled partial validation of "C" data 35, 65 , as the distributions of distances between loci can be measured and chromatin domains or TADs mapped using large or multiple probes 30, 31, 35, 65 . Furthermore, FISH or live-cell tagging technologies can be combined with immunofluorescence 66 or fluorescent fusion proteins for a variety of nuclear bodies and structures 51, [67] [68] [69] to gain insight into the chromatin state or nuclear compartment in which a locus resides. The most obvious advantage of these imaging approaches is that the position and status of a genomic locus can be measured in vivo and at the single-cell level in a cell population and in tissue sections, preserving cell-cell interactions. The disadvantages still remain the number of loci that can be measured at any one time, the need to genetically modify, transfect or otherwise treat the cells to generate fluorescent signals and the reliance on in vitro models of cell culture. The controls and standards for these techniques remain very different among laboratories. In microscopy, not only the experimental conditions but also the instrument itself and the image-analysis tools provide a huge number of variables. Standard pipelines for quantification of signal adapted to the noise (pixels), segmentation procedures and explicit distinction between 2D and 3D image analysis are, with some exceptions, lacking in the field. Finally, an effort must be made to deploy image-analysis codes in an open web format.
A final and very real challenge for imaging is performing experiments that are physiologically relevant; that is, finding conditions that minimize phototoxicity and potential artifacts of fixation. As the biological relevance of any observed event is primordial, it must be tracked over multiple conditions, and the statistical analysis of many individual event recordings must be considered integral to any microscopic approach. In addition to the need for high-resolution and rapid time-lapse imaging, we require means of storing, processing and analyzing the huge imaging data sets, as well as analytical tools that extract physical principles from the geometry and movement of chromatin. Only then can modeling of particle and fiber dynamics be applied to properly interpret the results of moving chromatin loci and integrate them with 'fixed' cell imaging or population-based molecular analyses.
3D/4D modeling
Theoretical approaches have become key for investigating the complexity of high-throughput 4D nucleome data. Two main approaches have been used over the last decades to model chromatin 70 . First, physical modeling, which has its roots in atomistic simulation methods, has been used to identify plausible spatial arrangements of the chromatin fiber, consistent with the laws of polymer physics. For example, these approaches have been implemented to interpret the decay of interaction frequencies with the genomic distance 71, 72 , the formation of domains of active and inactive chromatin 73 , the formation of domains by loop extrusion 74 , and epigenetic features such as chromatin types 75 , chromosome territories [76] [77] [78] and co-expression data 79 , among others. Furthermore, models have been directly compared to experimentally derived interaction data sets to characterize potential molecular mechanisms underlying chromosome folding 27, 74, [80] [81] [82] [83] . Second, the so-called restraint-based modeling has more recently been used to represent experimental observations from cell populations and single cells as sets of spatial restraints to fold the genome in 3D. The main experimental data driving these models come from 3C-based experiments, including single-cell Hi-C [84] [85] [86] [87] , as well as imaging 88 . Independently of the approach used for 3D/4D modeling, validating the accuracy of the resulting structural models is important and challenging. The difficulties arise not only from the diversity of chromatin arrangements in the cell population and the limited information about the native configuration/organization of the genome, but also from the lack of standards for sharing models. Currently, there is not a proposed standard for storing the coordinates of the resulting models, for linking the models with the experimental data used for its derivation, or for putting them in the context of previously known genomic information. More dramatically, no protocol exists to bridge the different levels of resolution on genome architecture and allow the final user to navigate from the base pair to the nucleosome array up to the global chromatin structure. Nowadays, each software uses its own formats, which are not easy to share, and key data to reproduce the computational experiment are not stored, making reproducibility a big challenge. Only recently have a significant number of models of genome organization at different levels of resolution been published 65, [89] [90] [91] [92] [93] [94] [95] . However, those are not centrally deposited, do not share standards and have only been partially validated. It is now time to identify guidelines for validating, annotating, and depositing 3D/4D genome models at all resolutions generated with software that can be easily shared and models that can be reproduced, mimicking efforts made by other communities. Initial steps toward validation and assessment of the resulting structural models are being taken 96 , including efforts such as those implemented in the virtual research environment of the Multiscale Complex Genomics Consortium (MuG), and this work needs to be continued and generalized in the future.
Experimental systems and functional validation assays
The ultimate validation of the data and models will come from predictions and their experimental testing by perturbing the biological systems of interest 97 . With the recently extended toolbox and the rise of biophysics and computational biology, the characterization of 4D genome structure and function is booming. Though technology has been an important driver for this progress, answering critical questions in the field such as how much of the structure dictates function and vice versa requires the selection of the appropriate biological systems and approaches to dissect the role of putative regulatory components. This issue is not novel, and the ENCODE project 98 has proposed a series of cell lines and tissues that could be used for these studies, which are subdivided into tiers 1, 2 and 3 in decreasing order of priority. Tier 1 cell lines have been used extensively to analyze chromatin contacts 99, 100 , but, to understand functional aspects of chromosome architecture dynamics, it is important to analyze the temporal order of events using nontransformed cells that can be differentiated or stimulated. For this reason, models such as human H1 or mouse embryonic stem (ES) cells that allow differentiation into several lineages [101] [102] [103] [104] , cell stimulation by hormone treatment 105 or genomic perturbations of key structural proteins 106, 107 can provide invaluable information. The collection of dense time series will be important for characterizing regulatory and stochastic differences over time. Likewise, analyses of multiple interrelated cell types along well-characterized differentiation paths, such as in the hematopoietic system 108 , are likely to be instrumental in the elaboration of predictive models. The analysis of carefully controlled cell differentiation systems should be complemented by in vivo work from sorted cells 103 , and particularly in the case of humans, a valuable alternative is the use of organoids obtained from differentiation of ES or iPS cells.
Furthermore, to go beyond correlations, it is important to manipulate the genome and uncouple effects on chromosome structure from effects on gene expression and DNA replication or repair. Multiple approaches are being developed toward this goal. In addition to knockdown and CRISPR-mediated gene knockout approaches, TALE-and CRISPR-based technology can be used to tether regulatory factors to study the effect on their target sites. This is true both for activation 109 and for repression 110 . Furthermore, recent developments allow multiplexing of these gene regulatory approaches 111 . Another strategy consists in tethering DNA domains to nuclear landmarks such as the lamina, which allows testing whether 'geographical' changes in gene position affect chromosome architecture and function 112 . TALE-based approaches can also be used to alter chromatin condensation without affecting transcription to study the effects on nuclear positioning of the cognate loci 113, 114 . Moreover, specific mutations can be induced at individual sequence elements to study whether changes at a given position in the genome can induce long-range effects elsewhere 115, 116 . Finally, new predictive models, such as PRISMR, are now able to predict the effect of structural variants in the topology of the genome 97 . Further developments of this rich toolbox should allow the performance of surgical genome technology experiments that should help researchers characterize the role of chromatin components in a quantitative way and tease apart correlations from causative roles.
Toward FAIR data, unified standards and RICH visualizations in 4D nucleome research
The quantity and quality of information that is being generated to explore and understand the organization, packaging and functions of the genome has grown tremendously in recent years, but many of these data cannot be fully exploited owing to the lack of standardization of procedures, lack of detailed information on various aspects of the setup and lack of data formats and visualization. Likewise, many current models cannot be used or compared among each other. To fully exploit the information that is being generated, both at the experimental and at the theoretical level, all these data should be made findable, accessible, interoperable and re-usable (FAIR) 117 . Here, we would like to propose good practice guidelines to ensure that data follow FAIR principles and to facilitate the implementation of common standards, both on the experimental and the modeling side ( Fig. 1 and Table 1) .
Concerning experimental approaches, we propose the following recommendations: (i) Data deposition. Deposit data in public repositories, providing rich and detailed metadata describing the materials, biological samples, experimental conditions and protocols. For imaging, the development of public repositories is still in discussion and in the testing phase, but it is highly recommended that primary images with appropriate metadata be stored and maintained until public repositories become available to the community. 
Deposited models
• Standard compliance.
• Accessible and traceable.
• Incorporate metadata (e.g., experimental set-ups).
• Should be selfconsistent.
• Synthetic data for validation mimicking controlled experiments are needed for validation.
• Clear definition of the basic physical assumptions.
• Benchmarked.
• Reliability metrics • Stable, traceable and accessible.
• Flexibility to adapt to different experimental set-ups.
• Cross-validate results with data not used in the refinement.
• Compare results with random models.
• Sustainable extension model to avoid missed information.
• Incorporate metadata on the experimental and modeling parts.
• (ii) Self-consistent input. Be certain that the data used for modeling is self-consistent and does not result a significant portion of contradictory models. (iii) Produce models of biological relevance. The resulting models shall reflect the native dynamics of the genome and provide predictable and experimentally testable hypotheses. (iv) Capture variability. Ensure that the models agree with the assumptions of one or multiple states observed by experiments. (v) Cross-validate. Compare the models with experimental data sets not used during modeling (e.g., imaging data compared to 3C-based data). (vi) Analyze the models. Generate models for RICH visualization (Representative, Interactive, Curated and Hosted) 119 to analyze them for additional nonrandom patterns that were not evident from used experimental data.
The time is ripe for the 4D nucleome community to discuss standards for the validation, deposition and analysis of data, as well as the resulting models needed for studying the spatiotemporal organization of the nucleus. Such criteria and standards could be inspired by the previous work that the structural biology community has carried out over the past decades for storing, disseminating, and visualizing data sets and models of proteins, nucleic acids and complex assemblies at different resolutions. To define these standards, we would like to propose that current initiatives in the 4D nucleome field collect recommendations by data producers and users, develop a consensus on validation protocols and identify software applications to perform such validation tasks. International experts in the 4D nucleome from experimental and computational fields, as well as visualization and data archiving, should meet to address a series of open questions that would bring this emerging field significantly closer to the desired standards. Finally, 4D nucleome research is young and booming. It can be predicted that data types and formats, as well as modeling procedures and capacities will evolve significantly in the coming years. It will therefore be important to evolve data and analytical standards correspondingly and ensure that old data, and not only the conclusions derived from them, will be 'lifted over to the newly defined standards to continue to be usable in the future, such that 4D nucleome knowledge will continue to increase without losing its history. 
